Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FG-2216 in renal anemia
NCT00456053Phase 2Completed
- Sponsor
- FibroGen
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of FG-2216 in anemia of chronic kidney disease, sponsored by FibroGen. Started Dec 2005; status: completed.
02
Drugs
FG-2216
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT00456053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00456053.